Eurofins Scientific SE
ERF
Classifica tra le azioni
#1375
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Prezzo delle azioni
$93.33
Capitalizzazione di mercato
$16.20B
Variazione (1 giorno)
-0.33%
Variazione (1 anno)
25.44%
Paese
LU
Scambia Eurofins Scientific SE (ERF)
Categoria
Healthcare
Rapporto P/B per Eurofins Scientific SE (ERF)
Rapporto P/B al October 2026 TTM: 3.77
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Eurofins Scientific SE, il rapporto P/B attuale (TTM) è 3.77. Alla fine del 2024, era pari a 1.76.
Storico del rapporto P/B per Eurofins Scientific SE da 2002 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 3.77 | 19.08% |
| 2025 | 3.17 | 80.09% |
| 2024 | 1.76 | -21.44% |
| 2023 | 2.24 | -17.00% |
| 2022 | 2.70 | -39.78% |
| 2021 | 4.48 | 29.46% |
| 2020 | 3.46 | 11.74% |
| 2019 | 3.10 | 43.35% |
| 2018 | 2.16 | -39.49% |
| 2017 | 3.57 | -10.21% |
| 2016 | 3.98 | -22.61% |
| 2015 | 5.14 | 5.20% |
| 2014 | 4.89 | -35.69% |
| 2013 | 7.60 | 59.42% |
| 2012 | 4.77 | 86.47% |
| 2011 | 2.56 | -24.98% |
| 2010 | 3.41 | 23.66% |
| 2009 | 2.76 | 17.40% |
| 2008 | 2.35 | -56.76% |
| 2007 | 5.43 | -28.77% |
| 2006 | 7.62 | 17.63% |
| 2005 | 6.48 | 88.98% |
| 2004 | 3.43 | 35.22% |
| 2003 | 2.54 | -9.88% |
| 2002 | 2.81 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 4.7411 | 25.60% |
US
|
|
| 3.0143 | -20.14% |
US
|
|
| 31.051 | 722.61% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 76.55% |
US
|
